Hshiou-ting Liu

Title: Hshiou-ting Liu: Innovator in Pharmaceutical Chemistry

Introduction

Hshiou-ting Liu is a prominent inventor based in Milpitas, California, known for his significant contributions to pharmaceutical chemistry. With a total of eight patents to his name, Liu has made remarkable advancements in the field of quinolone analogs and their therapeutic applications.

Latest Patents

Liu's latest patents include innovative formulations and methods related to quinolone analogs. One notable invention is a solid lyophilized form of 2-(4-Methyl-[1,4]diazepan-1-yl)-5-oxo-5H-7-thia-1,11b-diaza-benzo[c]fluorene-6-carboxylic acid (5-methyl-pyrazin-2-ylmethyl)-amide, along with the process for producing this solid form. This invention also encompasses compositions that include Compound I and its pharmaceutically acceptable salts, highlighting its therapeutic potential. Another significant patent involves the crystalline forms of the same compound and its salts, providing further options for therapeutic use.

Career Highlights

Throughout his career, Hshiou-ting Liu has worked with notable companies such as Dade Behring Inc. and Senhwa Biosciences, Inc. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.

Collaborations

Liu has collaborated with esteemed colleagues, including Yi Feng Zheng and Kenneth Cornell Kasper, enhancing the scope and impact of his research.

Conclusion

Hshiou-ting Liu's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as a leading inventor in the field. His work continues to influence the development of new therapeutic options.